 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Turning Point Therapeutics Inc. (TPTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-24 Sale | 2020-02-26 8:20 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $52.16 | $1,095,422 | 869,383 (Indirect Direct) | View |
| 2020-03-10 Sale | 2020-03-12 8:40 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 44,000 | $40.84 | $1,796,843 | 825,383 (Indirect Direct) | View |
| 2020-03-23 Sale | 2020-03-25 6:47 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 31,792 | $43.11 | $1,370,451 | 793,591 (Indirect Direct) | View |
| 2020-03-26 Sale | 2020-03-27 6:27 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $46.03 | $529,372 | 782,091 (Indirect Direct) | View |
| 2020-04-06 Sale | 2020-04-08 7:21 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $44.87 | $2,490,476 | 726,591 (Indirect Direct) | View |
| 2020-04-09 Sale | 2020-04-13 7:16 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 12,208 | $47.6 | $581,086 | 714,383 (Indirect Direct) | View |
| 2020-04-22 Sale | 2020-04-24 8:20 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $51.57 | $1,082,979 | 693,383 (Indirect Direct) | View |
| 2020-05-05 Sale | 2020-05-07 6:52 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $53.27 | $2,956,634 | 637,883 (Indirect Direct) | View |
| 2020-05-08 Sale | 2020-05-12 8:09 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $53.86 | $619,351 | 626,383 (Indirect Direct) | View |
| 2020-05-19 Sale | 2020-05-21 7:05 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $59.18 | $1,242,703 | 605,383 (Indirect Direct) | View |
| 2020-05-21 Purchase | 2020-05-26 4:17 pm | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director | 83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) | View |
| 2020-05-21 Purchase | 2020-05-26 5:55 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 4,166 | $60 | $249,960 | 26,872 (Direct) | View |
| 2020-05-21 Purchase | 2020-05-26 5:57 pm | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) | View |
| 2020-06-04 Sale | 2020-06-08 8:26 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $64.16 | $3,560,648 | 549,883 (Indirect Direct) | View |
| 2020-06-09 Sale | 2020-06-10 5:26 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 9,500 | $65.81 | $625,194 | 540,383 (Indirect Direct) | View |
| 2021-01-04 Sale | 2021-01-05 9:03 pm | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 10,300 | $120.43 | $1,240,406 | 284 (Direct) | View |
| 2021-01-07 Sale | 2021-01-08 9:08 pm | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 31,238 | $122.26 | $3,819,090 | 1,008 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 9:47 pm | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 30,000 | $126.73 | $3,801,918 | 2,704 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 9:50 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 25,000 | $125.89 | $3,147,363 | 0 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 8:28 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 60,000 | $137.48 | $8,249,038 | 50,195 (Direct) | View |
| 2021-03-04 Sale | 2021-03-05 8:56 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $105.04 | $3,734,075 | 3,845 (Direct) | View |
| 2021-03-08 Sale | 2021-03-09 7:26 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 20,000 | $109.8 | $2,195,939 | 6,483 (Direct) | View |
| 2021-03-22 Sale | 2021-03-24 9:54 pm | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 28,435 | $100.65 | $2,862,082 | 4,116 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-02 Option Award | 2020-03-02 7:11 pm | N/A 2030-03-01 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-06-15 Gift | 2020-06-17 6:47 pm | N/A 2029-07-23 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 30,000 | $0 | 0 (Direct) | View |
| 2020-06-15 Gift | 2020-06-17 6:47 pm | N/A 2029-07-23 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 30,000 | $0 | 30,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-17 6:47 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2020-06-15 Disposition | 2020-06-17 6:51 pm | N/A 2030-01-21 | Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director | 25,000 | $0 | 0 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 6:51 pm | N/A 2030-01-21 | Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director | 23,400 | $0 | 23,400 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 6:54 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | GORDON CARL L Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 6:58 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 7:02 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | Chacko Jacob Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 7:06 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 7:09 pm | N/A 2030-06-14 | Turning Point Therapeutics Inc. | TPTX | Gujrathi Sheila Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2020-07-13 Option Award | 2020-07-14 5:40 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 21,500 | $0 | 21,500 (Direct) | View |
| 2020-07-13 Option Award | 2020-07-14 5:40 pm | N/A 2030-07-12 | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 127,500 | $0 | 127,500 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-05 9:03 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 8,747 | $54.73 | 9,331 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-05 9:03 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 1,253 | $54.73 | 1,537 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-05 9:03 pm | N/A 2029-12-01 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 8,747 | $0 | 170,445 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-05 9:03 pm | N/A 2029-12-01 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 1,253 | $0 | 169,192 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 11,905 | $2.19 | 15,713 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,299 | $3.2 | 17,012 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 4,545 | $5.12 | 21,557 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 10,689 | $7.43 | 32,246 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A 2027-08-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 11,905 | $0 | 14,069 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A 2028-03-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,299 | $0 | 1,298 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A 2028-11-05 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 4,545 | $0 | 11,039 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A 2029-02-19 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 10,689 | $0 | 30,356 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 15,702 | $54.03 | 18,406 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 14,298 | $54.03 | 17,002 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A 2029-08-25 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 15,702 | $0 | 296,695 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A 2029-08-25 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 14,298 | $0 | 282,397 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:50 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 15,984 | $17 | 15,984 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:50 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 9,016 | $17 | 9,016 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:50 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 15,984 | $0 | 204,507 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:50 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 9,016 | $0 | 195,491 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:52 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 22,617 | $0 | 50,195 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:52 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 101,775 | $0 | 101,775 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:53 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,483 | $0 | 2,491 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:53 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 6,675 | $0 | 6,675 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:55 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 3,845 | $0 | 3,845 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:55 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 17,303 | $0 | 17,303 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:58 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 4,617 | $0 | 7,321 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:58 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 20,775 | $0 | 20,775 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:59 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 2,136 | $0 | 23,636 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:59 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 9,733 | $0 | 9,733 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 6:01 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 6,483 | $0 | 6,483 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 6:01 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 29,175 | $0 | 29,175 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 6:03 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 6,483 | $0 | 6,767 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 6:03 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 29,175 | $0 | 29,175 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 18,000 | $3.2 | 68,195 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 7,666 | $3.2 | 75,861 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 25,392 | $3.2 | 75,587 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 8,942 | $3.2 | 59,137 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 18,000 | $0 | 207,723 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 7,666 | $0 | 67,575 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 25,392 | $0 | 182,331 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 8,942 | $0 | 173,389 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 8:56 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $51.28 | 39,395 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 8:56 pm | N/A 2030-03-01 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $0 | 114,450 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-09 7:26 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 20,000 | $17 | 26,483 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-09 7:26 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 20,000 | $0 | 175,491 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,625 | $0 | 4,116 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 11,904 | $2.19 | 16,020 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,298 | $3.2 | 17,318 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 4,545 | $5.12 | 21,863 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 10,688 | $7.43 | 32,551 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A 2027-08-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 11,904 | $0 | 2,165 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A 2028-03-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,298 | $0 | 0 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A 2028-11-05 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 4,545 | $0 | 6,494 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A 2029-02-19 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 10,688 | $0 | 19,668 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-01 9:01 pm | N/A 2031-03-30 | Turning Point Therapeutics Inc. | TPTX | Bodem Barbara W. Director | 14,995 | $0 | 14,995 (Direct) | View |